BioLife Looks Strong For Fiscal Year 2026
Source: SeekingAlpha
2026-03-06 11:08:35 ET
The back-to-basics approach for BioLife ( BLFS ), which we described in our previous article, is working. The company is turning around in FY25 by going back to its core competence, biopreservation media (CryoStor and HypoThermosol) and the vials (one of two remaining businesses from an earlier M&A spree, together with ThawStar, that ended badly)....
Read the full article on Seeking Alpha
For further details see:
BioLife Looks Strong For Fiscal Year 2026
BioLife Solutions Inc.
NASDAQ: BLFS
BLFS Trading
-3.22% G/L:
$19.405 Last:
122,481 Volume:
$19.71 Open:
BLFS Latest News
February 26, 2026 04:03:00 pm
BioLife Solutions Reports Fourth Quarter and Full Year 2025 Financial Results from Continuing Operations
February 17, 2026 08:04:00 am
BioLife Solutions to Report Fourth Quarter and Full Year 2025 Financial Results and Business Update on February 26, 2026
BLFS Stock Data
$1,092,479,164
39,336,954
1.87%
67
N/A
Biotechnology & Life Sciences
Healthcare
US
Bothell
